<PAGE>
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
_____________________
SCHEDULE 13G
(Rule 13d-102)
INFORMATION STATEMENT PURSUANT TO RULES 13d-1 AND 13d-2
UNDER THE SECURITIES EXCHANGE ACT OF 1934
(Amendment No. ______)
Nitinol Medical Technologies, Inc.
----------------------------------
(Name of Issuer)
Common Stock, par value $.001 per share
---------------------------------------
(Title of Class of Securities)
65476T104
---------
(CUSIP Number)
<PAGE>
SCHEDULE 13G
CUSIP No. 65476T104 Page 2 of 7
____________________________________________________________________________
1. Name of Reporting Persons
S.S. or I.R.S. Identification Number of Above Persons
Fletcher Spaght, Inc.
ID#
____________________________________________________________________________
2. Check the Appropriate Box if a Member of a Group - Not Applicable
____________________________________________________________________________
3. SEC Use Only
____________________________________________________________________________
4. Citizenship or Place of Organization
State of Delaware
____________________________________________________________________________
Number of Shares Beneficially Owned By Each Reporting Person With;
5. Sole Voting Power:
626,470 shares (includes 111,818 shares which Fletcher Spaght, Inc. has
the right to acquire within 60 days after December 31, 1996);
____________________________________________________________________________
6. Shared Voting Power:
0 shares;
<PAGE>
CUSIP No. 65476T104 Page 3 of 7
____________________________________________________________________________
7. Sole Dispositive Power:
626,470 shares (includes 111,818 shares which Fletcher Spaght, Inc. has
the right to acquire within 60 days after December 31, 1996);
____________________________________________________________________________
8. Shared Dispositive Power:
0 shares.
____________________________________________________________________________
9. Aggregate Amount Beneficially Owned by Each Reporting Person.
626,470 shares (includes 111,818 shares which Fletcher Spaght, Inc. has
the right to acquire within 60 days after December 31, 1996).
____________________________________________________________________________
10. Check Box if the Aggregate Amount in Row (9) Excludes Certain Shares.
Not Applicable
____________________________________________________________________________
11. Percent of Class Represented by Amount in Row 9.
6.56%
____________________________________________________________________________
12. Type of Reporting Person.
CO
____________________________________________________________________________
<PAGE>
CUSIP No. 65476T104 Page 4 of 7
SCHEDULE 13G
Item 1(a). Name of Issuer:
- --------------------------
Nitinol Medical Technologies, Inc.
Item 1(b). Address of Issuer's Principal Executive Offices:
- ------------------------------------------------------------
27 Wormwood Street
South Boston, MA 02210
Item 2(a). Name of Person Filing:
- ----------------------------------
Fletcher Spaght, Inc.
Item 2(b). Address of Principal Business Office or, if none, Residence:
- ------------------------------------------------------------------------
222 Berkeley Street
Boston, MA 02116-3761
Item 2(c). Citizenship:
- ------------------------
State of Delaware
Item 2(d). Title of Class of Securities:
- -----------------------------------------
Common Stock, par value $.001 per share
Item 2(e). CUSIP Number:
- -------------------------
65476T104
<PAGE>
CUSIP No. 65476T104 Page 5 of 7
Item 3:
- -------
Not Applicable
Item 4. Ownership:
- -------------------
(a) Amount Beneficially Owned:
626,470 shares (includes 111,818 shares which Fletcher Spaght, Inc.
has the right to acquire within 60 days after December 31, 1996)
(b) Percent of Class:
6.56%
(c) Number of shares as to which such person has:
(i) sole power to vote or to direct the vote:
626,470 shares (includes 111,818 shares which Fletcher Spaght,
Inc. has the right to acquire within 60 days after December 31,
1996);
(ii) shared power to vote or to direct the vote:
0 shares;
(iii) sole power to dispose or to direct the disposition of:
626,470 shares (includes 111,818 shares which Fletcher Spaght,
Inc. has the right to acquire within 60 days after December 31,
1996);
(iv) shared power to dispose or to direct the disposition of:
0 shares;
Item 5. Ownership of Five Percent or Less of a Class:
- ------------------------------------------------------
Not Applicable
<PAGE>
CUSIP No. 65476T104 Page 6 of 7
Item 6. Ownership of More Than Five Percent on Behalf of Another Person:
- -------------------------------------------------------------------------
Not Applicable
Item 7. Identification and Classification of the Subsidiary Which Acquired the
Security Being Reported on by the Parent Holding Company:
- -------------------------------------------------------------------------------
Not Applicable
Item 8. Identification and Classification of Members of the Group:
- ------------------------------------------------------------------
Not Applicable
Item 9. Notice of Dissolution of Group:
- ----------------------------------------
Not Applicable
Item 10. Certification:
- ------------------------
Not Applicable
<PAGE>
CUSIP No. 65476T104 Page 7 of 7
SIGNATURE
After reasonable inquiry and to the best of my knowledge and belief, I
certify that the information set forth in this statement is true, complete and
correct.
February 7, 1997
------------------------------
Date
FLETCHER SPAGHT, INC.
By: /s/ R. John Fletcher
---------------------------
Name: R. John Fletcher
Title: Chief Executive Officer
